University of California San Francisco
Give to UCSF
Zuranolone (Zurzuvae), the first pill for patients suffering from postpartum depression, is expected to be available by the end of 2023. Though it may relieve depressive symptoms, it has some drawbacks such as sedation and dangers in breastfeeding.
A clinical trial showed that MDMA, the so-called psychedelic drug also known as "ecstasy" or "molly," can be a powerful new tool in treating people with moderate-to-severe PTSD.
Using both cannabis and tobacco increases depression and anxiety risk, highlighting the need for integrated support, says UC San Francisco study.
A new intervention may help “night owl” kids adjust to their natural sleep-cycle rhythms, fulfill their school responsibilities and avoid depression.
An Oregon prison is testing a Norwegian-inspired approach to prison reform that’s designed to bring greater humanity to corrections and improve conditions for staff and prison residents. This includes reducing the use of solitary confinement.
Manvir, a young cancer patient, worked with the UCSF Benioff Oakland Braddock Emotional Support Team (BEST) to alleviate his emotional and physical pain from his treatments. A new gift will help expand BEST behavioral and mental health services to young cancer patients and their families.
UCSF Langley Porter Psychiatric Hospital will welcome patients to a larger and modernized space on August 19 in UCSF Mount Zion Medical Center.
Three cheers! The American Heart Association has recognized UCSF’s Wellness Team and a number of other organizations across the U.S. “for their commitment to building a culture of health and well-being.” We’ll learn more about the honor and how the Wellness Team makes UCSF’s wellness their mission.
Adverse experiences early in childhood and early life have been linked to lifelong health consequences.
In this Q&A, UCSF experts offer tips on how to stay protected during heat waves, and how to be aware of treat heat-related illnesses.
A rare burst of visual creativity is seen occasionally in patients with frontotemporal dementia. A UCSF-led study offers new insights into how this talent develops as key areas of the brain degenerate.
UCSF oncology scientist Paddy O'Leary won the 112th running of the Dipsea Race, the country's oldest trail race, on June 11. We caught up with him to learn more about his running, work and what drives him.
